Priser
Platform
Blog
Om os
Download
002437
Harbin Gloria Pharmaceuticals Co
Shenzhen Stock Exchange (Hong Kong)
0

Om

Harbin Gloria Pharmaceuticals Co., Ltd. is a pharmaceutical company that plays a vital role in the healthcare sector by developing, manufacturing, and marketing a range of medicinal products. Known for its commitment to advancing pharmaceutical technology, Harbin Gloria Pharmaceuticals focuses on providing high-quality and affordable healthcare solutions. The company's product portfolio includes therapeutic drugs and innovative treatments targeting various medical conditions, which serve both domestic and international markets. As a key player in the pharmaceutical industry, Harbin Gloria Pharmaceuticals continually invests in research and development, contributing to the advancement of medical treatments and improving patient outcomes. The company's operations and products are crucial in addressing the growing demand for effective pharmaceuticals, reflecting its significant impact on the healthcare landscape globally.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HARBIN GLORIA PHARMACEUTICALS CO MED ENDAVU: Køb Harbin Gloria Pharmaceuticals Co ($002437) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Harbin Gloria Pharmaceuticals Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker002437
Land
Kina
Antal medarbejdere2.703
Hjemmesidegloria.cc
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0CNH
'14
0,01CNH
'15
0,03CNH
'16
0,05CNH
'17
0,02CNH
'18
0,01CNH
'19
Ex-udbytte-dato28. jun. 2019
Udbytteafkast0,33%